BioSpace News Archive

Business

PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

PROCEPT® BioRobotics Corporation, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, reported unaudited financial results for the quarter ended June 30, 2022.

August 4, 2022
·
12 min read
Business

CymaBay Therapeutics to Report Second Quarter of 2022 Financial Results on Thursday, August 11, 2022

CymaBay Therapeutics, Inc. announced that it will host a conference call and live audio webcast on Thursday, August 11, 2022 at 4:30 p.m. Eastern Time to discuss financial results for the second quarter ended June 30, 2022 and to provide a business update.

August 4, 2022
·
1 min read
Business

Lyell Immunopharma Reports Second Quarter 2022 Financial Results and Business Highlights

Lyell Immunopharma, Inc., a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, provided business highlights and reported financial results for the second quarter of 2022.

August 4, 2022
·
11 min read
Business

Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced that the Company intends to release its second quarter 2022 financial results on Thursday, August 11, 2022.

August 4, 2022
·
1 min read
Business

Collegium Reports Second Quarter 2022 Financial Results

Collegium Pharmaceutical, Inc., a leading, diversified specialty pharmaceutical company, reported its financial results for the quarter ended June 30, 2022 and provided a corporate update.

August 4, 2022
·
15 min read
Business

Iovance Biotherapeutics Reports Second Quarter and First Half 2022 Financial Results and Corporate Updates

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported second quarter and first half 2022 financial results and corporate updates.

August 4, 2022
·
13 min read
Business

Applied Molecular Transport Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, provided a corporate update and reported financial results for the second quarter ended June 30, 2022.

August 4, 2022
·
9 min read
BioCapital

Synthetic Biologics to Participate in the BTIG Biotechnology Conference 2022

Synthetic Biologics, Inc. announced that Company’s management will participate in one-on-one investor meetings at the BTIG Biotechnology Conference 2022, to be held virtually and in New York City from August 8-9, 2022.

August 4, 2022
·
1 min read
Business

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, provided a corporate update and reported financial results for the second quarter ended June 30, 2022.

August 4, 2022
·
9 min read
Press Releases

Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business Updates

Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines, reported financial results and business highlights for the second quarter 2022.

August 4, 2022
·
19 min read